Congress’s delay of new federal hemp restrictions protects near-term patient access and gives lawmakers more time to pursue a comprehensive policy that supports safety, clinical oversight and responsible state regulation.

As a healthcare professional working directly with patients, Jonathan "Gio" Stelly argues that Congress should delay the November 12 restrictions on hemp-derived THC beverages and instead pursue a regulatory framework grounded in science, consumer safety, and patient access.